Proliferation Networks Associated with Ki-67 and Progesterone Receptor Status in Invasive Breast Carcinomas

被引：0
|
作者：
Rosa, F. E. [1 ]
Canevari, R. A. [2 ]
Marchi, F. P. [3 ]
Busso, A. [4 ]
Moraes Neto, F. A. [5 ]
Caldeira, J. R. F. [5 ]
Reis, E. M. [6 ]
Verjovski-Almeida, S. [6 ]
Rogatto, S. R. [7 ]
机构：
[1] UNESP, Clin Hosp, Botucatu, SP, Brazil
[2] Inst Res & Dev UniVap, Lab Biomed Vibrat Spect, Sao Jose Dos Campos, Brazil
[3] CIPE Hosp AC Camargo, Creat Vis Res Lab Bioinformat, Sao Paulo, Brazil
[4] Hosp AC Camargo Fund Antonio Prudente, CIPE, Sao Paulo, Brazil
[5] Amaral Carvalho Hosp, Jau, Brazil
[6] Sao Paulo Univ USP, Inst Chem, Sao Paulo, Brazil
[7] Sao Paulo State Univ, Botucatu, SP, Brazil
来源：
EUROPEAN JOURNAL OF CANCER | 2012年 / 48卷
关键词：
D O I：
10.1016/S0959-8049(12)70967-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
272
引用
收藏
页码：S66 / S66
页数：1
相关论文
共 50 条
  • [1] Proliferation-associated genes correlated to hormonal receptors and Ki-67 status in breast carcinomas
    Rosa, F. E.
    Canevari, R. A.
    Neto, F. A. Moraes
    Caldeira, J. R. F.
    Reis, E. M.
    Verjovski-Almeida, S.
    Rogatto, S. R.
    EJC SUPPLEMENTS, 2008, 6 (09): : 135 - 135
  • [2] Estrogen Receptor, Progesterone Receptor, HER2/neu, P53 and Ki-67 status of Male Breast Carcinomas in Pakistan
    Jamal, Shahid
    Mushtaq, Huma
    Mubarik, Azhar
    Malik, Tariq Masood
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2009, 10 (06) : 1067 - 1070
  • [3] Stability of Estrogen Receptor (ER), Progesterone Receptor (PR), Ki-67 and HER2 Status in Breast Carcinomas After Neoadjuvant Chemotherapy (NAC)
    Ginter, Paula
    Nagar, Himanshu
    Liu, Yifang
    Shin, Sandra
    Varma, Sonal
    MODERN PATHOLOGY, 2015, 28 : 46A - 46A
  • [4] Stability of Estrogen Receptor (ER), Progesterone Receptor (PR), Ki-67 and HER2 Status in Breast Carcinomas After Neoadjuvant Chemotherapy (NAC)
    Ginter, Paula
    Nagar, Himanshu
    Liu, Yifang
    Shin, Sandra
    Varma, Sonal
    LABORATORY INVESTIGATION, 2015, 95 : 46A - 46A
  • [5] Cytology and histology grading, hormone receptor status, Ki-67 and C-erB 2 in breast carcinomas
    Putti, T
    Choi, Y
    Kanaan, H
    Win, K
    Goldschmid, B
    Patel, F
    LABORATORY INVESTIGATION, 1999, 79 (01) : 50A - 50A
  • [6] Proliferation marker Ki-67 in early breast cancer
    Urruticoechea, A
    Smith, IE
    Dowsett, M
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (28) : 7212 - 7220
  • [7] Ki-67 as a Prognostic Biomarker in Invasive Breast Cancer
    Davey, Matthew G.
    Hynes, Sean O.
    Kerin, Michael J.
    Miller, Nicola
    Lowery, Aoife J.
    CANCERS, 2021, 13 (17)
  • [8] Comparison of Automated and Manual Assessment of Ki-67 Proliferative Activity in Invasive Breast Carcinomas (IBCs)
    Kwon, Y.
    Ro, J.
    Lee, E. S.
    Kang, H. S.
    Kim, S. W.
    Kim, K. J.
    Lee, G. K.
    LABORATORY INVESTIGATION, 2013, 93 : 51A - 51A
  • [9] The Relationship of Ki-67 Over-expression with Clinicopathological Prognostic Parameters in Invasive Breast Carcinomas
    DemIr, Hale
    Ozturk, Tulin
    Gulle, Bugra Taygun
    Ilvan, Sennur
    TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY, 2021, 36 (04): : 415 - 422
  • [10] Comparison of Automated and Manual Assessment of Ki-67 Proliferative Activity in Invasive Breast Carcinomas (IBCs)
    Kwon, Y.
    Ro, J.
    Lee, E. S.
    Kang, H. S.
    Kim, S. W.
    Kim, K. J.
    Lee, G. K.
    MODERN PATHOLOGY, 2013, 26 : 51A - 51A
12345